` Comparison: IMUX vs ABBV - Alpha Spread

IMUX
vs
ABBV

Over the past 12 months, IMUX has underperformed ABBV, delivering a return of +2% compared to the ABBV's +6% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
IMUX
ABBV
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

IMUX Intrinsic Value
HIDDEN
Show
ABBV Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Immunic Inc
NASDAQ:IMUX
1.11 USD
Abbvie Inc
NYSE:ABBV
230.625 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
IMUX, ABBV

IMUX
ABBV
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Immunic Inc
Revenue
Abbvie Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
IMUX, ABBV

IMUX
ABBV
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Immunic Inc
NASDAQ:IMUX
Abbvie Inc
NYSE:ABBV
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

IMUX
0%
ABBV
71.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Immunic Inc
Abbvie Inc

Operating Margin

IMUX
0%
ABBV
34.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Immunic Inc
Abbvie Inc

Net Margin

IMUX
0%
ABBV
6.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Immunic Inc
Abbvie Inc

FCF Margin

IMUX
0%
ABBV
29.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Immunic Inc
Abbvie Inc

ROE

IMUX
-1 653.1%
ABBV
15 221.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Immunic Inc
Abbvie Inc

ROA

IMUX
-299.4%
ABBV
3.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Immunic Inc
Abbvie Inc

ROIC

IMUX
4 898.1%
ABBV
14%
LTM 3Y Avg 5Y Avg 10Y Avg
Immunic Inc
Abbvie Inc

ROCE

IMUX
-1 702.4%
ABBV
22.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Immunic Inc
Abbvie Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
IMUX, ABBV

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
IMUX, ABBV

Performance Gap Between IMUX and ABBV
HIDDEN
Show

Performance By Year
IMUX, ABBV

Loading
IMUX
ABBV
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare IMUX to other stocks
PNEXF
Pharnext SCA
More expensive
vs IMUX
AMGN
Amgen Inc
More expensive
vs IMUX
GILD
Gilead Sciences Inc
More expensive
vs IMUX
VRTX
Vertex Pharmaceuticals Inc
More expensive
vs IMUX
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett